Generic Development of Topical Dermatologic Products, Part II: Quality by Design for Topical Semisolid Products
Journal Title: The AAPS Journal - Year 2013, Vol 15, Issue 3
Abstract
The emergence of quality by design as a relatively new systematic science and risk-based approach has added a new dimension to pharmaceutical development and manufacturing. This review attempts to discuss the quality by design elements and concepts applied for topical semisolid products. Quality by design begins with defining a quality target product profile as well as critical quality attributes. Subsequently, this is followed by risk identification/risk analysis/risk evaluation to recognize critical material attributes and critical process parameters, in conjunction with design of experiments or other appropriate methods to establish control strategies for the drug product. Several design-of-experiment examples are included as practical strategies for the development and optimization of formulation and process for topical drug products.
Authors and Affiliations
Rong-Kun Chang, Andre Raw, Robert Lionberger, Lawrence Yu
Keywords
Related Articles
- EP ID EP681122
- DOI 10.1208/s12248-013-9472-8
- Views 38
- Downloads 0
Modeling the Effects of Vaccination and Treatment on Pandemic Influenza
In this paper, we demonstrate the uses of some simple mathematical models for the study of disease dynamics in a pandemic situation with a focus on influenza. These models are employed to evaluate the effectiveness of va...
Formation of Activity Cliffs Is Accompanied by Systematic Increases in Ligand Efficiency from Lowly to Highly Potent Compounds
Activity cliffs (ACs) are defined as pairs of structurally similar compounds sharing the same biological activity but having a large difference in potency. Therefore, ACs are often studied to rationalize structure-activi...
Aqueous and cosolvent solubility data for drug-like organic compounds
Recently 2 QSPR-based in silico models were developed in our laboratories to predict the aqueous and non-aqueous solubility of drug-like organic compounds. For the intrinsic aqueous solubility model, a set of 321 structu...
DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles
The online version of this article (doi:10.1208/s12248-010-9185-1) contains supplementary material, which is available to authorized users.
Chitosan and sodium alginate—Based bioadhesive vaginal tablets
Metronidazole was formulated in mucoadhesive vaginal tablets by directly compressing the natural cationic polymer chitosan, loosely cross-linked with glutaraldehyde, together with sodium alginate with or ine cellulose (M...